The United States represents one of the largest contributors to the travel vaccines market, driven by high volumes of outbound international travel, increasing awareness of travel-related infectious diseases, and a well-established healthcare infrastructure. The growing number of Americans traveling for business, tourism, education, and humanitarian purposes has significantly increased demand...